Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.
In this video, Million Hearts® Executive Director Laurence Sperling, MD, reviews the missed opportunities in cardiovascular event prevention as well as what you can do to help bridge the gaps.
In this video, Herman Taylor, Jr, MD, MPH, explains how the findings from the Jackson Heart Study question the specifics of making the right diagnosis at the right time among African Americans.
Ermias D. Belay, MD, Associate Director for Epidemiologic Science, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for...
